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How plants transform the central
biosynthetic intermediate strictosidine
into thousands of divergent alkaloids has
remained unresolved. Stavrinides et al.
discover a nuclear-localized alcohol
dehydrogenase homolog responsible for
conversion of strictosidine aglycone to
tetrahydroalstonine that appears to
interact with an upstream pathway
enzyme.
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The extraordinary chemical diversity of the plant-
derived monoterpene indole alkaloids, which include
vinblastine, quinine, and strychnine, originates from
a single biosynthetic intermediate, strictosidine agly-
cone. Here we report for the first time the cloning of
a biosynthetic gene and characterization of the corre-
spondingenzymethat actsat this crucialbranchpoint.
This enzyme, an alcohol dehydrogenase homolog,
converts strictosidine aglycone to the heteroyo-
himbine-type alkaloid tetrahydroalstonine. We also
demonstrate how this enzyme, which uses a highly
reactive substrate, may interact with the upstream
enzyme of the pathway.
INTRODUCTION
The monoterpene indole alkaloids (MIAs) are a highly diverse
family of natural products that are produced in a wide variety
of medicinal plants. Over 3000 members of this natural product
class, which includes compounds such as quinine, vinblastine,
reserpine, and yohimbine, are derived from a common biosyn-
thetic intermediate, strictosidine aglycone (O’Connor and Mar-
esh, 2006). How plants transform strictosidine aglycone into
divergent structural classes has remained unresolved.
The recent availability of transcriptome and genome data has
dramatically accelerated the rate at which newplant biosynthetic
genes are discovered. All genes that lead to strictosidine agly-
cone have been recently cloned from the well-characterized
medicinal plant Catharanthus roseus, which produces over 100
MIAs (De Luca et al., 2014). However, gene products that act
on strictosidine aglycone have not been identified in any plant,
despite decades of effort. Attempts have been hampered in
part by the reactivity and instability of strictosidine aglycone. In
C. roseus, there are at least twomajor pathway branches derived
from strictosidine aglycone (O’Connor and Maresh, 2006). One
pathway is hypothesized to lead to the aspidosperma and the
iboga classes to yield the precursors of vinblastine, while the
other is expected to lead to alkaloids of the heteroyohimbine
type (Figure 1A). These alkaloids have diverse biological activ-
ities: vinblastine is used as an anticancer agent (Kaur et al.,336 Chemistry & Biology 22, 336–341, March 19, 2015 ª2015 The Au2014) and the heteroyohimbines have a range of pharmacolog-
ical uses (Costa-Campos et al., 1998; Elisabetsky and Costa-
Campos, 2006). While it is unknown how many C. roseus en-
zymes use strictosidine aglycone as a substrate, there is clearly
more than one enzyme that acts at this crucial branchpoint.
The biochemical pathway leading from strictosidine aglycone
to the heteroyohimbine alkaloids has been previously investi-
gated using both crude plant extracts and biomimetic chemistry.
Reduction of strictosidine aglycone with NaBH4 or NaCNBH3
yielded the heteroyohimbines ajmalicine (raubasine), tetrahy-
droalstonine, and 19-epi-ajmalicine, which differ only in the
stereochemical configuration at carbons 15, 19, and 20, in
various ratios (Figure 1B) (Brown et al., 1977; Kan-Fan and
Husson, 1978, 1979, 1980). These three diastereomers were
again observed, also in varying relative amounts, when crude
C. roseus protein extracts were incubated with strictosidine
aglycone and NADPH, but not in the absence of NADPH (Rueffer
et al., 1979; Stoeckigt et al., 1976, 1977, 1983; Zenk, 1980).
Collectively, these observations indicate that the heteroyohim-
bines result directly from the reduction of strictosidine aglycone
and that an NADPH-dependent enzyme is implicated in this
process. However, no gene encoding such an enzyme has
been identified. Here we report the discovery of a reductase
that converts strictosidine aglycone to the heteroyohimbine
alkaloid tetrahydroalstonine.
RESULTS AND DISCUSSION
Given that heteroyohimbine biosynthesis likely requires reduc-
tion of an iminium present in strictosidine aglycone (Figure 1B),
we used a publically available RNA-seq database that we
recently generated (Gongora-Castillo et al., 2012) to search for
C. roseus candidates displaying homology to enzyme classes
known to reduce the carbonyl functional group. The alcohol de-
hydrogenases (ADHs), enzymes that reduce aldehydes and
ketones to alcohols, were chosen as the initial focus. As part of
a screen of ADHs that are upregulated in response to methyl
jasmonate (Gongora-Castillo et al., 2012), a hormone known to
upregulate alkaloid biosynthesis, we identified a candidate an-
notated as sinapyl alcohol dehydrogenase (Supplemental Infor-
mation). When heterologously expressed and purified from
E. coli (Figure S1), and assayed with strictosidine aglycone and
NADPH, this candidate yielded a product with a mass consistent
with a heteroyohimbine (m/z 353.1855), thereby implicating thisthors
Figure 1. The Monoterpene Indole Alkaloids
(A) Representative monoterpene indole alkaloids derived from strictosidine and strictosidine aglycone found in Catharanthus roseus.
(B) Heteroyohimbine biosynthesis.enzyme in the important structural branchpoint of the MIA
biosynthetic pathway (Figure 2A).
To determine the identity of the alkaloid product, the enzyme
was incubated with purified strictosidine (4.3mg) in the presence
of strictosidine glucosidase (SGD), which generated strictosidine
aglycone in situ to best mimic physiologically relevant condi-
tions. The major product (approximately 1 mg) was isolated
by preparative thin-layer chromatography and exhibited an 1H-
NMR and 13C-NMR spectrum matching an authentic standard
of tetrahydroalstonine (Figure 2B; Figure S2). Hemscheidt and
Zenk (1985) previously reported the isolation of an enzyme that
produced tetrahydroalstonine, although this protein was purified
only 35-fold from C. roseus cell cultures. Consistent with Hem-
scheidt and Zenk’s (1985) nomenclature, we named this enzyme
tetrahydroalstonine synthase (THAS). A minor enzymatic prod-
uct was produced in yields too low for NMR characterization,
but had amass and Rf value consistent with ajmalicine, a stereo-
isomer of tetrahydroalstonine (Figure S2). When applied to
normal phase liquid chromatography conditions, ajmalicine
and tetrahydroalstonine could be resolved, indicating that the
enzyme produces approximately 95% tetrahydroalstonine (Fig-
ure 3; Supplemental Information). We also silenced this gene in
C. roseus seedlings using virus-induced gene silencing (VIGS)
(Liscombe and O’Connor, 2011). LC-mass spectrometry (MS)
analysis of the silenced leaf tissue showed a statistically signifi-
cant decrease (approximately 50%) of a peak with a mass and
retention time consistent with a heteroyohimbine, suggesting
that this enzyme is involved in this biosynthetic pathway branch
in vivo (Figure S2). A 50% reduction in product levels uponChemistsilencing has been observed for other physiologically relevant
biosynthetic genes using the VIGS approach in both C. roseus
(Asada et al., 2013; Geu-Flores et al., 2012) and another
well-studied medicinal plant, opium poppy (Desgagne-Penix
and Facchini, 2012; Chen and Facchini, 2014). Therefore,
THAS is likely a major producer of tetrahydroalstonine in vivo,
although additional, undiscovered C. roseus enzymes could
also contribute to production of this compound. While we could
not resolve tetrahydroalstonine and its stereoisomer ajmalicine
in the silenced crude extracts, the levels of the ajmalicine-
derived alkaloid serpentine remain the same, suggesting that
silencing of THAS does not substantially affect ajmalicine levels
and consequently that THAS does not play a major role in the
biosynthesis of ajmalicine in planta.
Small-scale assays using LC-MS tomonitor product formation
indicated that NADPH was required for the reaction, although
NADH could also be utilized (Figure S1). Efforts to accurately
measure the steady state kinetic constants of this enzyme
were complicated because strictosidine aglycone reacts with
nucleophiles, opening the possibility that the substrate reacts
with components in the reaction or the enzyme. This reactivity
has already been associated with a plant defense mechanism
involving strictosidine aglycone-mediated aggregation of pro-
teins in C. roseus (Guirimand et al., 2010). Nevertheless, we ob-
tained estimatedKm and kcat values (Figure S1). To support these
kinetic data, we also performed isothermal titration calorimetry
(ITC) with THAS in the presence of NADPH and strictosidine
aglycone. Titration of THAS with NADPH indicated that the co-
substrate binds first with a Kd of 1.5 ± 0.1 mM (DH (cal/mol)ry & Biology 22, 336–341, March 19, 2015 ª2015 The Authors 337
Figure 2. Activity Assays of THAS
Enzyme reactions were performed at 25C for 30 min and assayed using a mass spectrometer in tandem with ultraperformance liquid chromatography.
(A) The total ion chromatogram for m/z 353 (red trace) and m/z 351 (purple trace) from 1 to 4 min is shown. Top trace: THAS (50 nM), SGD (6 nM), strictosidine
(200 mM), NADPH (200 mM); bottom trace: same reaction in the absence of THAS. The y axis represents normalized ion abundance as a percentage relative to
1.00e8 detected by selected ion monitoring at m/z 353 and 351.
(B) Portion of the 1H-NMR spectrum of the isolated enzymatic product compared with an authentic standard of tetrahydroalstonine.2310 ± 123.2; DS (cal/mol/deg) 34.2 ± 0.3) (Figure S1). The agly-
cone substrate does not appear to bind in the absence of
NADPH, suggesting that the enzyme utilizes an ordered binding
mechanism in which NADPH binds first. However, titration of
the THAS-NADPH complex with strictosidine aglycone led to
formation of a precipitate when concentrations of strictosidine
aglycone exceeded 60 mM, preventing calculation of an accurate
Kd. Collectively, the ITC data for THAS are consistent with an
ordered Bi-Bi mechanism, a kinetic mechanism that has been
reported for similar ADHs such as cinnamyl alcohol dehydroge-
nase (Charlier and Plapp, 2000; Lee et al., 2013).
The amino acid sequence of THAS was subjected to a
BLAST alignment against the C. roseus transcriptome (Gon-
gora-Castillo et al., 2012), as well as the NCBI (Figure S3). The
closest characterized homologs of THAS are sinapyl alcohol
dehydrogenase (Populus tremuloides, 64% amino acid identity),
cinnamyl alcohol dehydrogenase (Populus tomentosa, 64%) and
8-hydroxygeraniol dehydrogenase (C. roseus, 63%), which are
zinc-containing medium chain ADHs (Bomati and Noel, 2005;
Lee et al., 2013).
Strictosidine aglycone can rearrange into several isomers (Fig-
ure 1B), and while it has been reported that the dominant isomer
is cathenamine (Gerasimenko et al., 2002; Stoeckigt et al., 1977),
equilibration in solution with other isomers occurs (Brown and
Leonard, 1979; Stoeckigt et al., 1983). Reduction of cathen-
amine or epi-cathenamine (Figure 1B) by a reductase would
require reduction of the carbon-carbon double bond of an338 Chemistry & Biology 22, 336–341, March 19, 2015 ª2015 The Auenamine; alternatively, Stoeckigt et al. (1983) and Zenk (1980)
suggested that the iminium isomer is reduced (Figure 1B).
THAS may catalyze the stereoselective formation of tetrahy-
droalstonine by selectively binding the correct isomer of the sub-
strate for reduction, thereby relying on the inherent propensity for
the enamine and imine to tautomerize under physiological condi-
tions. Given that three diastereomers, ajmalicine, tetrahydroal-
stonine, and 19-epi-ajmalicine, can be obtained from chemical
reduction of strictosidine aglycone, this is a chemically reason-
able proposal. An alternative hypothesis is that THAS catalyzes
enamine-imine tautomerization in addition to reduction. The
difficulties associated with obtaining accurate kinetic data
in this system, as well as the inherent reactivity of the strictosi-
dine aglycone, make answering these questions using enzy-
mology approaches challenging. However, identification and
comparison with enzymes that generate other heteroyohimbine
diastereomers will likely provide the basis for a more definitive
mechanism of product specificity.
Recent research has highlighted that plant secondary metab-
olite biosynthetic pathways often are compartmentalized in
different subcellular locations. While microscopy experiments
have demonstrated that most of the early steps of monoterpene
indole alkaloid biosynthesis inC. roseus take place in the cytosol
(Courdavault et al., 2014), the enzyme that synthesizes stricto-
sidine is located in the vacuole, and the enzyme SGD, which
deglycosylates strictosidine, contains a nuclear localization
signal and is in the nucleus, a highly unusual site for secondarythors
Figure 4. THAS Is Targeted to the Nucleus via aMonopartite Nuclear
Localization Signal (NLS) and Interacts with SGD
(A) C. roseus cells were transiently cotransformed with plasmids expressing
either THAS-YFP (upper row), YFP-THAS (middle row), or the NLS deleted
version of THAS (lower row) and plasmids encoding the nuclear CFPmarker or
the nucleocytosolic CFP marker (second column). Colocalization of the fluo-
rescence signals appears in yellow when merging the two individual (green/
red) false color images (third column). Cell morphology is observed with dif-
ferential interference contrast (DIC) (fourth column).
(B) THAS and SGD interactions were analyzed by BiFC in C. roseus cells
transiently transformed by plasmids encoding fusions indicated on the top
(fusion with the split YFPN fragment) and on the left (fusion with split YFPC
fragment). bZIP63 was used as a positive BiFC control and to evaluate the
specificity of THAS and SGD interactions. The images are merges of the YFP
BiFC channel (magenta false color) with the DIC channel to show the nuclear
localization of the interactions. Bars, 10 mm.
Figure 3. LC-MSPerformed under Normal Phase Conditions (Hydro-
philic Interaction Liquid Chromatography) Showing Separation of
Ajamlicine (Retention Time of 0.49 min) and Tetrahydroalstonine
(THA, Retention Time 0.67 min)
THAS produces approximately 95% of the tetrahydroalstonine (THA) diaste-
reomer. The y axis represents normalized ion abundance as a percentage
detected by selected ion monitoring at m/z 353.metabolite biosynthesis (Guirimand et al., 2010). Notably, a motif
resembling a class V nuclear localization sequence (Kosugi et al.,
2008) was observed in THAS (K214K215K216R217). Microscopy of
C. roseus cells transformed with YFP-tagged THAS confirmed
the nuclear location of this enzyme, while deletion of the KKKR
sequence disrupted the localization (Figure 4A; Figure S4). This
is one of the very few examples of secondary metabolism that
is localized to the nucleus (Saslowsky et al., 2005).
Given the reactivity of strictosidine aglycone (Guirimand et al.,
2010), metabolic channeling via a protein-protein interaction
between SGD and the enzyme immediately downstream may
be necessary to protect the substrate. Pull down experiments
between SGD and THAS gave partially positive but inconclusive
results (Figure S4). However, when we used bimolecular
fluorescence complementation (BiFC) in C. roseus cells, we
observed an interaction between SGD and THAS (Figure 4B).
While this interaction generated a diffuse nuclear fluorescent
signal when the C-terminal end of SGD was fused to the split-
YFP fragment, a sickle-shaped signal was observed when
both SGD and THAS were expressed with free C-terminal
ends (YFPN-SGD and YFPC-THAS). Such a signal was also
observed for SGD self-interactions (Guirimand et al., 2010)
and likely results from the formation of SGD complexes over
1.5 MDa (Luijendijk et al., 1998). Similar experiments with
SGD and an upstream MIA biosynthetic enzyme, loganic acid
methyl transferase, failed to show an interaction, highlighting
the specificity of this interaction (Figure S4). The fact that
THAS interacts with SGD provides further support for the phys-
iological relevance of THAS in planta. As strictosidine aglycone
is reactive and most likely toxic in vivo, it has been proposed
that this molecule is produced by the plant in response to attack
(Guirimand et al., 2010). The nuclear localization of THAS might
be an evolutionary mechanism designed to channel this mole-Chemistcule into a more stable product when no such defense is
required. Identification of additional nuclear-localized biosyn-
thetic enzymes in C. roseus and other heteroyohimbinery & Biology 22, 336–341, March 19, 2015 ª2015 The Authors 339
producing plants may provide more insight into the reasons for
this unusual localization pattern.
SIGNIFICANCE
Many of the monoterpene indole alkaloid structural classes
are generated at the SGD junction. Here we report the first
identification of a biosynthetic gene that acts directly down-
stream of SGD. The enzyme, an ADH homolog, generates a
heteroyohimbine alkaloid by reducing one of the isomers
of strictosidine aglycone. Unusually, this enzyme is located
in the nucleus and may interact with its upstream partner,
SGD. The discovery of the THAS gene represents the
completion of a major branch of monoterpene indole alka-
loid biosynthesis, which will now allow reconstruction of
heteroyohimbines and heteroyohimbine analogs in heterol-
ogous hosts. This discovery is a crucial first step in under-
standing how the structural diversity of MIAs is controlled.
EXPERIMENTAL PROCEDURES
The THAS gene (accession number KM524258) was cloned into pOPINF and
expressed in Rosetta 2 pLysS E. coli cells (Novagen) with induction of expres-
sionwith 0.1mM isopropyl b-D-1-thiogalactopyranoside. Cultures were grown
at 18C for 16 hr, with shaking at 200 rpm. His-tagged THASwas purified using
a HisTrap FF 5-ml column (GE Healthcare). SGD expression and purification
was done as described for THAS using the expression system described pre-
viously by Yerkes et al. (2008). Purified THAS and SGDwere used in all assays.
Strictosidine was enzymatically synthesized from tryptamine and a crude
methanol extract of snowberries (Symphoricarpos albus) enriched in secolo-
ganin prepared as previously described (Geerlings et al., 2001). Strictosidine
aglycone was generated in situ prior to addition of THAS by incubation of
strictosidine and SGD in the appropriate solution for 10 min, at which time
strictosidine was completely converted to the aglycone.
Steady state kinetic analyses were performed with 50 nM THAS and 6 nM
SGD,50mMphosphatebuffer (pH7.5), 200mMNADPH, andan internal caffeine
standard (50 mM). All LC-MS measurements were performed on AQUITY ultra-
performance liquid chromatography with a Xevo TQ-S mass spectrometer.
For VIGS, a 330-bp fragment of THAS was cloned into the pTRV2u vector as
described (Geu-Flores et al., 2012). The resulting pTRV2u-THAS construct
was used to silence THAS in C. roseus seedlings essentially as described
(Liscombe and O’Connor, 2011).
The subcellular localization of THAS was studied by creating fluorescent
fusion proteins using the pSCA-cassette YFPi plasmid (Guirimand et al.,
2009, 2010). The capacity of interaction of THAS and SGD was characterized
by BiFC assays using THAS PCR product cloned via SpeI into the
pSPYCE(MR) plasmid (Waadt et al., 2008), which allows expression of THAS
fused to the carboxy-terminal extremity of the split YFPC fragment (YFPC-
THAS). The pSCA-SPYNE173-SGD and pSPYNE(R)173-SGD plasmids (Guir-
imand et al., 2010) were used to express SGD fused to the amino-terminal or
carboxy-terminal extremity of the split YFPN fragment (SGD-YFPN and YFPN-
SGD, respectively). THAS self-interactions were analyzed via additional clon-
ing of the THAS PCR product into the pSCA-SPYNE173 and pSCA-SPYCE(M)
plasmids (Guirimand et al., 2010) to express THAS-YFPN and THAS-YFPC,
respectively. Transient transformation of C. roseus cells by particle bombard-
ment and fluorescence imaging were performed following the procedures
previously described (Guirimand et al., 2009, 2010).
Complete experimental details are included in the Supplemental
Information.
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